Bamco Inc Bridge Bio Pharma, Inc. Transaction History

Bamco Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$11.38 - $53.41 $5.55 Million - $26 Million	-487,447 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$46.87 - $64.24 $9.59 Million - $13.2 Million	-204,713 Reduced 29.58%	487,447 $22.8 Million
Q2 2021 Aug 13, 2021	SELL	$46.47 - $63.93 $14.9 Million - $20.6 Million	-321,566 Reduced 31.72%	692,160 $42.2 Million
Q1 2021 May 19, 2021	BUY	$55.47 - $72.35 $54.8 Million - $71.5 Million	987,850 Added 3817.63%	1,013,726 $62.4 Million
Q4 2020 Feb 12, 2021	BUY	$38.38 - $71.11 $993,120 - $1.84 Million	25,876 New	25,876 $1.84 Million

285

170M

7.41M

2.61M

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $3.88B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

Get notified when there are updates to the investment portfolio of Bamco Inc , based on Form 13F filings with the SEC.

Stay updated on Bamco Inc with notifications on news.